Filip J. Baert
Yvoir, WAL, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications
Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group.
Journal: Journal of Crohn's & colitis
Published: August 09, 2026
Multi-stakeholder Delphi consensus on future care for inflammatory bowel disease in Belgium.
Journal: Acta gastro-enterologica Belgica
Published: July 08, 2026
The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program.
Journal: Therapeutic advances in gastroenterology
Published: March 24, 2026
Perioperative risk factors for disease recurrence following ileocecal resection in Crohn's disease: implications for early immunosuppressive therapy.
Journal: Updates in surgery
Published: February 23, 2026
The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results From the Phase II GLADIATOR Trial.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 22, 2025
Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure.
Journal: Acta gastro-enterologica Belgica
Published: October 13, 2025
Long-Term Safety of Upadacitinib in Patients With Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 08, 2025
The Effect of Dose Intensification After Secondary Loss of Response to Ustekinumab in Crohn's Disease: Results of the REScUE Study.
Journal: Gastroenterology
Published: September 13, 2025
Building a Robust Investigator-Initiated Platform: The I-CARE Experience.
Journal: Clinical pharmacology and therapeutics
Published: September 04, 2025
Ustekinumab in Ulcerative Colitis: A Real-Life Effectiveness Study Across Multiple Belgian Centers (SULTAN).
Journal: Journal of clinical medicine
Published: July 07, 2025
Long-term safety of ustekinumab in Crohn's disease: Descriptive analysis from an observational post-authorisation safety study using I-CARE cohort data.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: July 03, 2025
Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease.
Journal: Inflammatory bowel diseases
Published: June 04, 2025
Last Updated: 09/26/2026